Dr. Daisy Escobar, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 17
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 28
Licensed in Alabama since 2022, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
AL license MD.43486 (first issued 2022; active) -
Internal Medicine Physician
AL license L4849R -
Medical Oncology Physician
AL license L4849R -
Student in an Organized Health Care Education/Training Program
AL license L4849R
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mobile Infirmary Medical Center Mobile, AL
- USA Health HCA Providence Hospital, LLC Mobile, AL
- USA Health University Hospital Mobile, AL
- USA Health Children's & Women's Hospital Mobile, AL
Medical groups
- USA Health - Mci Business Services LLC (26 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 28
- Services billed
- 75
- Patients’ average age
- 72
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Mobile, AL | 23 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Mobile, AL | 16 |
| Tafinlar (dabrafenib mesylate) | 15 |
| Mekinist (trametinib dimethyl sulfoxide) | 14 |
| Ibrance (palbociclib) | 12 |
| Brukinsa (zanubrutinib) | 12 |
| Hydroxyzine Hcl Other prescribers in Mobile, AL | 12 |
| Jakafi (ruxolitinib phosphate) | 11 |
| Nubeqa (darolutamide) | 11 |
| Acyclovir Other prescribers in Mobile, AL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 37 companies reported 124 payments worth $2,695 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $257 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $190 |
| Regeneron Healthcare Solutions, Inc. | $189 |
| Daiichi Sankyo Inc. | $178 |
| Janssen Biotech, Inc. | $178 |
| AbbVie Inc. | $152 |
| Servier Pharmaceuticals LLC | $151 |
| Celgene Corporation | $145 |
| Food and Beverage | $2,695 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.